| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| resveratrol | aryl hydrocarbon receptor | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.04 | investigational | unknown |
| resveratrol | aryl hydrocarbon receptor | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.04 | investigational | unknown |
| resveratrol | rac-alpha serine/threonine-protein kinase | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.05 | investigational | inhibitor |
| resveratrol | rac-alpha serine/threonine-protein kinase | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.05 | investigational | inhibitor |
| resveratrol | arachidonate 15-lipoxygenase | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | arachidonate 15-lipoxygenase | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | arachidonate 5-lipoxygenase | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | arachidonate 5-lipoxygenase | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | amyloid beta a4 protein | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.13 | investigational | unknown |
| resveratrol | amyloid beta a4 protein | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.13 | investigational | unknown |
| resveratrol | carbonyl reductase [nadph] 1 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | inhibitor |
| resveratrol | carbonyl reductase [nadph] 1 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | inhibitor |
| resveratrol | c-type lectin domain family 14 member a | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | c-type lectin domain family 14 member a | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | casein kinase ii subunit alpha | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | casein kinase ii subunit alpha | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | estrogen receptor alpha | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.01 | investigational | unknown |
| resveratrol | estrogen receptor alpha | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.01 | investigational | unknown |
| resveratrol | integrin alpha-5 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | integrin alpha-5 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | integrin beta-3 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | integrin beta-3 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | far upstream element-binding protein 2 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | far upstream element-binding protein 2 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | melatonin receptor type 1a | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | melatonin receptor type 1a | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | melatonin receptor type 1b | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | melatonin receptor type 1b | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | ribosyldihydronicotinamide dehydrogenase [quinone] | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | ribosyldihydronicotinamide dehydrogenase [quinone] | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | nuclear receptor subfamily 1 group i member 2 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | nuclear receptor subfamily 1 group i member 2 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | nuclear receptor subfamily 1 group i member 3 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | nuclear receptor subfamily 1 group i member 3 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | phosphatidylinositol 4-kinase type 2-beta | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | phosphatidylinositol 4-kinase type 2-beta | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | peroxisome proliferator-activated receptor alpha | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | peroxisome proliferator-activated receptor alpha | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.02 | investigational | antagonist |
| resveratrol | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.02 | investigational | antagonist |
| resveratrol | prostaglandin g/h synthase 1 | small molecule | Successful target | TTD , drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational,phase 3 | inhibitor |
| resveratrol | prostaglandin g/h synthase 1 | small molecule | Successful target | TTD , drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational,phase 3 | inhibitor |
| resveratrol | prostaglandin g/h synthase 2 | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.03 | investigational | inhibitor |
| resveratrol | prostaglandin g/h synthase 2 | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.03 | investigational | inhibitor |
| resveratrol | nad-dependent deacetylase sirtuin-1 | NA | Clinical trial target | TTD , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.31 | phase 3 | unknown |
| resveratrol | nad-dependent protein deacetylase sirtuin-1 | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.31 | investigational | unknown |
| resveratrol | nad-dependent protein deacetylase sirtuin-1 | small molecule | NA | drugbank , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.31 | investigational | unknown |
| resveratrol | nad-dependent deacetylase sirtuin-1 | NA | Clinical trial target | TTD , DGIDB | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
0.31 | phase 3 | unknown |
| resveratrol | solute carrier family 2, facilitated glucose transporter member 1 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | solute carrier family 2, facilitated glucose transporter member 1 | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | alpha-synuclein | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | unknown |
| resveratrol | alpha-synuclein | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | unknown |
| resveratrol | tyrosine--trna ligase, cytoplasmic | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Giant Cell Arteritis[MeSHID:D013700] Systemic Scleroderma[MeSHID:D012595] Colorectal Cancer[MeSHID:D015179] Rheumatoid Arthritis[MeSHID:D001172] |
NA | investigational | inhibitor |
| resveratrol | tyrosine--trna ligase, cytoplasmic | small molecule | NA | drugbank | Herpesviridae Infections[MeSHID:D006566] Herpes Labialis[MeSHID:D006560] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | investigational | inhibitor |
| click here to return to the previous page | ||||||||